Professor Peter Shaw

Clinical Professor
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone +61 2 9845 0000
Fax +61 2 9845 2171

Website Related website

Map

Research interests

Drug pharmacokinetics, cellular immunotherapy

International links

Netherlands

(University Medical Centre, Utrecht,) Busulphan pharmacokinetics and pharmacodynamics

United States

(Children''s Oncology group) Full members

United States

(Pediatric Blood and Marrow Transplant Consortium) Full member

Selected grants

2007

  • Toward a Best Practice of Emerging Technologies: PGD and HLA Typing for Paediatric Transplantation; Strong K, Ankeny R, O'Brien T, Shaw P, Jordens C, O'Brien T, Carter S, Kerridge I; Cancer Council New South Wales/Research Project Grants.

2006

  • Using melphalan blood concentrations to reduce toxicity and improve transplant outcome in adult myel; Trotman J, Nath C, Shaw P, Kerridge I; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Sillence, D., Waters, K., Donaldson, S., Shaw, P., Ellaway, C. (2012). Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI. In Society for the Study of Inborn Errors of Metabolism (Eds.), JIMD Reports - Case and Research Reports, 2011/2, (pp. 103-106). Heidelberg: Springer.
  • Kilo, T., Shaw, P. (2009). Cord blood transplantation for paediatric non-malignant conditions. In Bhattacharya, Niranjan; Stubblefield, Phillip (Eds.), Frontiers of Cord Blood Science, (pp. 161-194). London: Springer.

Journals

  • Hale, G., Arora, M., Ahn, K., He, W., Camitta, B., Bishop, M., Bitan, M., Cairo, M., Chan, K., Childs, R., et al (2013). Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience. Bone Marrow Transplantation, 48(8), 1056-1064. [More Information]
  • Clancy, L., Blyth, E., Simms, R., Micklethwaite, K., Ma, C., Burgess, J., Antonenas, V., Shaw, P., Gottlieb, D. (2013). Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution. Biology of Blood and Marrow Transplantation, 19(5), 725-734. [More Information]
  • Blyth, E., Clancy, L., Simms, R., Ma, C., Burgess, J., Deo, S., Byth Wilson, K., Dubosq, M., Shaw, P., Micklethwaite, K., Gottlieb, D. (2013). Donor-derived CMV specific T-cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood, 121(18), 3745-3758. [More Information]
  • Savic, R., Cowan, M., Dvorak, C., Pai, S., Pereira, L., Bartelink, I., Boelens, J., Bredius, R., Wynn, R., Cuvelier, G., et al (2013). Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 19(11), 1608-1614. [More Information]
  • Garcia, M., Chapman, J., Shaw, P., Gottlieb, D., Ralph, A., Craig, J., Tong, A. (2013). Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biology of Blood and Marrow Transplantation, 19(7), 1046-1058. [More Information]
  • Mitchell, R., Nivison-Smith, I., Anazodo, A., Tiedemann, K., Shaw, P., Teague, L., Fraser, C., Carter, T., Tapp, H., Alvaro, F., et al (2013). Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Pediatric Transplantation, 17(6), 582-588. [More Information]
  • Seale, H., Trung, L., Mackie, F., Kennedy S E, S., Boros, C., Marshall, H., Tidswell, J., Shaw, P., Montgomery, K., MacIntyre, C. (2012). A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine, 30(49), 7027-7031. [More Information]
  • Bartelink, I., Boelens, J., Bredius, R., Egberts, A., Wang, C., Bierings, M., Shaw, P., Nath, C., Hempel, G., Zwaveling, J., et al (2012). Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients: Towards Individualized Dosing. Clinical Pharmacokinetics, 51(5), 331-345. [More Information]
  • Hsieh, S., Hibbert, S., Shaw, P., Ahern, V., Arora, M. (2011). Association of Cyclophasophamide Use with Dental Developmental Defects and Salivary Gland Dysfunction in Recipients of Childhood Antineoplastic Therapy. Cancer, 117(10), 2219-2227. [More Information]
  • Mehr, S., Kakakios, A., Shaw, P., Webster, R., Kemp, A. (2011). Beware the lymphopenia: A case of severe combined immunodeficiency. Journal of Paediatrics and Child Health, 47(8), 565-567. [More Information]
  • Ladenstein, R., Potschger, U., Siabalis, D., Garaventa, A., Bergeron, C., Lewis, I., Stein, J., Kohler, J., Shaw, P., Holter, W., et al (2011). Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion. Journal of Clinical Oncology, 29(4), 441-448. [More Information]
  • Park, J., Scott, J., Stewart, C., London, W., Naranjo, A., Santana, V., Shaw, P., Cohn, S., Matthay, K. (2011). Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study. Journal of Clinical Oncology, 29(33), 4351-4357. [More Information]
  • Suryani, S., Fulcher, D., Nanan, B., Nanan, R., Wong, M., Shaw, P., Gibson, J., Williams, A., Tangye, S. (2010). Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood, 115(3), 519-529. [More Information]
  • Hale, K., Shaw, P., Dalla-Pozza, L., MacIntyre, C., Isaacs, D., Sorrell, T. (2010). Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. British Journal of Haematology, 149(2), 263-272. [More Information]
  • Shaw, P., Kan, F., Ahn, K., Spellman, S., Aljurf, M., Ayas, M., Burke, M., Cairo, M., Chen, A., Davies, S., et al (2010). Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood, 116(19), 4007-4015. [More Information]
  • Nath, C., Shaw, P., Trotman, J., Zeng, L., Duffull, S., Hegarty, G., McLachlan, A., Gurney, H., Kerridge, I., Kwan, Y., Joshua, D., et al (2010). Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. British Journal of Clinical Pharmacology, 69(5), 484-497. [More Information]
  • Zeng, L., Blair, E., Nath, C., Shaw, P., Earl, J., Stephen, K., Montgomery, K., Coakley, J., Hodson, E., Stormon, M., McLachlan, A. (2010). Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation. British Journal of Clinical Pharmacology, 70(4), 567-579. [More Information]
  • Samuel, G., Strong, K., Kerridge, I., Jordens, C., Ankeny, R., Shaw, P. (2009). Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do "saviour siblings" have in paediatric transplantation? Archives of Disease in Childhood, 94(4), 317-320. [More Information]
  • Moore, A., Shaw, P., Hallahan, A., Carter, T., Kilo, T., Nivison-Smith, I., O'Brien, T., Tapp, H., Teague, L., Wilson, S., et al (2009). Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group. Medical Journal of Australia, 190(3), 121-125. [More Information]
  • Zeng, L., Nath, C., Shaw, P., Earl, J., McLachlan, A. (2009). HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children. Biomedical Chromatography, 23(1), 92-100. [More Information]
  • Petterson, T., Gabriel, M., Tiedermann, K., Teague, L., Shaw, P., Baker, D., Bolton-Jones, R., Tapp, H., Oswald, C., Vowels, M., et al (2009). Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children''s haematology and oncology group. Bone Marrow Transplantation, 43, 207-215. [More Information]
  • Zeng, L., Nath, C., Blair, E., Shaw, P., Stephen, K., Earl, J., Coakley, J., McLachlan, A. (2009). Population Pharmacokinetics of Acyclovir in Children and Young People with Malignancy after Administration of Intravenous Acyclovir or Oral Valacyclovir. Antimicrobial Agents and Chemotherapy, 53(7), 2918-2927. [More Information]
  • Pulsipher, M., Boucher, K., Wall, D., Frangoul, H., Duval, M., Goyal, R., Shaw, P., Haight, A., Grimley, M., Grupp, S., et al (2009). Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood, 114(7), 1429-1436. [More Information]
  • Gea-Banacloche, J., Masur, H., da Cuhna, C., Chiller, T., Kirchoff, L., Shaw, P., Tomblyn, M., Cordonnier, C. (2009). Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplantation, 44(8), 489-494. [More Information]
  • Bhadri, V., Lee-Horn, L., Shaw, P. (2009). Safety and tolerability of cidofovir in high-risk pediatric patients. Transplant infectious disease : an official journal of the Transplantation Society, 11(4), 373-9. [More Information]
  • Ozkaynak, M., Sahdev, I., Gross, T., Levine, J., Cheerva, A., Richards, M., Rozans, M., Shaw, P., Kadota, R. (2008). A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors - A pediatric blood and marrow transplant consortium study. Journal of Pediatric Hematology / Oncology, 30(3), 204-209. [More Information]
  • Alexander, S., Smith, N., Hu, M., Verran, D., Shun, A., Dorney, S., Smith, A., Webster, B., Shaw, P., Lammi, A., Stormon, M. (2008). Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant. New England Journal of Medicine, 358(4), 369-374. [More Information]
  • Khan, N., Cisterne, A., Devidas, M., Shuster, J., Hunger, S., Shaw, P., Bradstock, K., Bendall, L. (2008). Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics. Leukemia and lymphoma, 49(4), 710-718. [More Information]
  • Zeng, L., Nath, C., Shaw, P., Earl, J., McLachlan, A. (2008). HPLC-fluorescence assay for acyclovir in children. Biomedical Chromatography, 22(8), 879-887. [More Information]
  • Nath, C., Earl, J., Pati, N., Stephen, K., Shaw, P. (2008). Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients. British Journal of Clinical Pharmacology, 66(1), 50-59. [More Information]
  • Nath, C., McLachlan, A., Shaw, P., Coakley, J., Earl, J. (2007). Amphotericin B Dose Optimization in Children with Malignant Diseases. Chemotherapy, 53(2), 142-147. [More Information]
  • Nath, C., Shaw, P. (2007). Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Current Clinical Pharmacology, 2(1), 75-91. [More Information]
  • Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K., Gottlieb, D. (2007). Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13(6), 707-714. [More Information]
  • Howman-Giles, R., Shaw, P., Uren, R., Chung, D. (2007). Neuroblastoma and Other Neuroendocrine Tumors. Seminars in Nuclear Medicine, 37(4), 286-302. [More Information]
  • Nath, C., Shaw, P., Trotman, J., Zhang, Y. (2007). Pharmacokinetics of melphalan in myeloma patients undergoing an autograft. Bone Marrow Transplantation, 40(7), 707-8. [More Information]
  • Hong, Y., Shaw, P., Tattam, B., Nath, C., Earl, J., Stephen, K., McLachlan, A. (2007). Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases. European Journal of Clinical Pharmacology, 63(2), 165-172. [More Information]
  • Nath, C., Shaw, P., Montgomery, K., Earl, J. (2007). Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. British Journal of Clinical Pharmacology, 64(2), 151-164. [More Information]
  • Kakakios, A., Tugwell, H., Shaw, P. (2006). Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatric Blood and Cancer, 47, 327-9. [More Information]
  • Cuss, A., Avery, D., Cannons, J., Yu, L., Nichols, K., Shaw, P., Tangye, S. (2006). Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. Journal of Immunology, 176(3), 1506-1516. [More Information]
  • Bateman, C., Kesson, A., Shaw, P. (2006). Pancreatitis and adenoviral infection in children after blood and marrow transplantation. Bone Marrow Transplantation, 38(12), 807-811. [More Information]
  • Gandhi, M., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P., Prince, H., Wolf, M., Clarke, K., Underhill, C., et al (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12(2), 460-464.
  • Hong, Y., Shaw, P., Nath, C., Yadav, S., Stephen, K., Earl, J., McLachlan, A. (2006). Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases. Antimicrobial Agents and Chemotherapy, 50(3), 935-942. [More Information]
  • Halliday, C., Hoile, R., Sorrell, T., James, G., Yadav, S., Shaw, P., Bleakley, M., Bradstock, K., Chen, S. (2006). Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. British Journal of Haematology, 132(4), 478-486. [More Information]
  • Nath, C., Shaw, P., Montgomery, K., Earl, J. (2005). Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation. British Journal of Clinical Pharmacology, 59(3), 314-324. [More Information]
  • Shaw, P., Nath, C., Berry, A., Earl, J. (2004). Busulphan Given As Four Single Daily Doses Of 150 Mg/M2 Is Safe And Effective In Children Of All Ages. Bone Marrow Transplantation, 34(3), 197-205.
  • Gluckman, E., Shaw, P., Arcese, W., Michel, G., Sanz, G., Chan, K., Takahashi, T., Ortega, J., Filipovich, A., Locatelli, F., et al (2004). Factors Associated With Outcomes Of Unrelated Cord Blood Transplant: Guidelines For Donor Choice. Experimental Hematology, 32(4), 397-407. [More Information]
  • Antonenas, V., Shaw, P., Bradstock, K. (2004). Letter: Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation. Bone Marrow Transplantation, 34(8), 739.
  • Barbaric, D., Curtin, J., Pearson, L., Shaw, P. (2004). Role Of Hydrochloric Acid In The Treatment Of Central Venous Catheter Infections In Children With Cancer. Cancer, 101(8), 1866-1872. [More Information]
  • Locatelli, F., Labopin, M., Ortega, J., Meloni, G., Dini, G., Messina, C., Yaniv, I., Fagioli, F., Castel, V., Shaw, P., et al (2003). Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood, 101(4), 1611-1619.
  • Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K., Filipovich, A., Takahashi, T., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P., et al (2003). Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group Analysis. Blood, 102(13), 4290-4297.
  • Milledge, J., Shaw, P., Mansour, A., Williamson, S., Bennetts, B., Roscioli, T., Curtin, J., Christodoulou, J. (2002). Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood, 100(3), 774-777.
  • Smith, A., Shaw, P., Webster, B., Lammi, A., Gaskin, K., Diaz, S., Sharma, P. (2002). Intermittent 20q- and consistent i(7q) in a patient with Shwachman-Diamond syndrome. Pediatric Hematology and Oncology, 19(7), 525-528.

Conferences

  • Strong, K., Kerridge, I., Jordens, C., Ankeny, R., Shaw, P., O'Brien, T., Carter, S., Barlow-Stewart, K. (2008). Creating 'Saviour Siblings' for transplantation-discrepancy between parental wishes and clinical practice. 50th American Society of Hematology Annual Meeting and Exposition ASH 2008, United States: American Society of Hematology.
  • Park, J., Stewart, C., London, W., Santana, V., Shaw, P., Cohn, S., Matthay, K. (2006). A topotecan-containing induction regimen for treatment of high risk neuroblastoma. 2006 American Society of Clinical Oncology (ASCO) Annual Meeting, United States: American Society of Clinical Oncology.
  • Antonenas, V., Bradstock, K., Shaw, P., Gottlieb, D. (2006). Comparison between TNC and CD34+cell counts reported pre-cryopreservation of unrelated cord blood (UCB) units and those observed at the time of their transplantation. 2nd International Conference 'Strategies in Tissue Engineering', United Kingdom: Informa Healthcare.
  • Petterson, T., Tiedemann, K., Teague, L., Shaw, P., Baker, D., Bolton-Jones, R., Oswald, C., O'Brien, T. (2006). Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: A report from the Australian and New Zealand children's haematology and oncology group (anzchog). 32nd Annual Meeting of the American Society for Blood and Marrow Transplantation, United States: Elsevier Ltd.
  • Stephen, K., Montgomery, K., Bateman, C., Calandra, G., Shaw, P. (2006). Successful mobilisation, harvest, and transplant of stem cells following AMD3100 in 3 paediatric patients. The Australian experience. 32nd Annual Meeting of the American Society for Blood and Marrow Transplantation, United States: Elsevier Ltd.
  • Spavor, M., Ahern, V., Shaw, P., Steinbeck, K., Somerville, E., Somerville, H. (2005). Beyond brain tumours and cognition: Neurological complications in long-term survivors of childhood non-central nervous system malignancies. 26th International Epilepsy Congress (IEC), United States: Blackwell Publishers.
  • Antonenas, V., Kerridge, I., Thomson, A., Trickett, A., Shaw, P., Bradstock, K. (2004). Development of a policy for the storage and disposal of cryopreserved haematopoietic progenitor cells for the NSW BMT Network Laboratories. Australian and New Zealand Transplant Society.

2013

  • Hale, G., Arora, M., Ahn, K., He, W., Camitta, B., Bishop, M., Bitan, M., Cairo, M., Chan, K., Childs, R., et al (2013). Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience. Bone Marrow Transplantation, 48(8), 1056-1064. [More Information]
  • Clancy, L., Blyth, E., Simms, R., Micklethwaite, K., Ma, C., Burgess, J., Antonenas, V., Shaw, P., Gottlieb, D. (2013). Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution. Biology of Blood and Marrow Transplantation, 19(5), 725-734. [More Information]
  • Blyth, E., Clancy, L., Simms, R., Ma, C., Burgess, J., Deo, S., Byth Wilson, K., Dubosq, M., Shaw, P., Micklethwaite, K., Gottlieb, D. (2013). Donor-derived CMV specific T-cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood, 121(18), 3745-3758. [More Information]
  • Savic, R., Cowan, M., Dvorak, C., Pai, S., Pereira, L., Bartelink, I., Boelens, J., Bredius, R., Wynn, R., Cuvelier, G., et al (2013). Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 19(11), 1608-1614. [More Information]
  • Garcia, M., Chapman, J., Shaw, P., Gottlieb, D., Ralph, A., Craig, J., Tong, A. (2013). Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biology of Blood and Marrow Transplantation, 19(7), 1046-1058. [More Information]
  • Mitchell, R., Nivison-Smith, I., Anazodo, A., Tiedemann, K., Shaw, P., Teague, L., Fraser, C., Carter, T., Tapp, H., Alvaro, F., et al (2013). Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Pediatric Transplantation, 17(6), 582-588. [More Information]

2012

  • Seale, H., Trung, L., Mackie, F., Kennedy S E, S., Boros, C., Marshall, H., Tidswell, J., Shaw, P., Montgomery, K., MacIntyre, C. (2012). A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine, 30(49), 7027-7031. [More Information]
  • Bartelink, I., Boelens, J., Bredius, R., Egberts, A., Wang, C., Bierings, M., Shaw, P., Nath, C., Hempel, G., Zwaveling, J., et al (2012). Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients: Towards Individualized Dosing. Clinical Pharmacokinetics, 51(5), 331-345. [More Information]
  • Sillence, D., Waters, K., Donaldson, S., Shaw, P., Ellaway, C. (2012). Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI. In Society for the Study of Inborn Errors of Metabolism (Eds.), JIMD Reports - Case and Research Reports, 2011/2, (pp. 103-106). Heidelberg: Springer.

2011

  • Hsieh, S., Hibbert, S., Shaw, P., Ahern, V., Arora, M. (2011). Association of Cyclophasophamide Use with Dental Developmental Defects and Salivary Gland Dysfunction in Recipients of Childhood Antineoplastic Therapy. Cancer, 117(10), 2219-2227. [More Information]
  • Mehr, S., Kakakios, A., Shaw, P., Webster, R., Kemp, A. (2011). Beware the lymphopenia: A case of severe combined immunodeficiency. Journal of Paediatrics and Child Health, 47(8), 565-567. [More Information]
  • Ladenstein, R., Potschger, U., Siabalis, D., Garaventa, A., Bergeron, C., Lewis, I., Stein, J., Kohler, J., Shaw, P., Holter, W., et al (2011). Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion. Journal of Clinical Oncology, 29(4), 441-448. [More Information]
  • Park, J., Scott, J., Stewart, C., London, W., Naranjo, A., Santana, V., Shaw, P., Cohn, S., Matthay, K. (2011). Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study. Journal of Clinical Oncology, 29(33), 4351-4357. [More Information]

2010

  • Suryani, S., Fulcher, D., Nanan, B., Nanan, R., Wong, M., Shaw, P., Gibson, J., Williams, A., Tangye, S. (2010). Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood, 115(3), 519-529. [More Information]
  • Hale, K., Shaw, P., Dalla-Pozza, L., MacIntyre, C., Isaacs, D., Sorrell, T. (2010). Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. British Journal of Haematology, 149(2), 263-272. [More Information]
  • Shaw, P., Kan, F., Ahn, K., Spellman, S., Aljurf, M., Ayas, M., Burke, M., Cairo, M., Chen, A., Davies, S., et al (2010). Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood, 116(19), 4007-4015. [More Information]
  • Nath, C., Shaw, P., Trotman, J., Zeng, L., Duffull, S., Hegarty, G., McLachlan, A., Gurney, H., Kerridge, I., Kwan, Y., Joshua, D., et al (2010). Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. British Journal of Clinical Pharmacology, 69(5), 484-497. [More Information]
  • Zeng, L., Blair, E., Nath, C., Shaw, P., Earl, J., Stephen, K., Montgomery, K., Coakley, J., Hodson, E., Stormon, M., McLachlan, A. (2010). Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation. British Journal of Clinical Pharmacology, 70(4), 567-579. [More Information]

2009

  • Kilo, T., Shaw, P. (2009). Cord blood transplantation for paediatric non-malignant conditions. In Bhattacharya, Niranjan; Stubblefield, Phillip (Eds.), Frontiers of Cord Blood Science, (pp. 161-194). London: Springer.
  • Samuel, G., Strong, K., Kerridge, I., Jordens, C., Ankeny, R., Shaw, P. (2009). Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do "saviour siblings" have in paediatric transplantation? Archives of Disease in Childhood, 94(4), 317-320. [More Information]
  • Moore, A., Shaw, P., Hallahan, A., Carter, T., Kilo, T., Nivison-Smith, I., O'Brien, T., Tapp, H., Teague, L., Wilson, S., et al (2009). Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group. Medical Journal of Australia, 190(3), 121-125. [More Information]
  • Zeng, L., Nath, C., Shaw, P., Earl, J., McLachlan, A. (2009). HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children. Biomedical Chromatography, 23(1), 92-100. [More Information]
  • Petterson, T., Gabriel, M., Tiedermann, K., Teague, L., Shaw, P., Baker, D., Bolton-Jones, R., Tapp, H., Oswald, C., Vowels, M., et al (2009). Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children''s haematology and oncology group. Bone Marrow Transplantation, 43, 207-215. [More Information]
  • Zeng, L., Nath, C., Blair, E., Shaw, P., Stephen, K., Earl, J., Coakley, J., McLachlan, A. (2009). Population Pharmacokinetics of Acyclovir in Children and Young People with Malignancy after Administration of Intravenous Acyclovir or Oral Valacyclovir. Antimicrobial Agents and Chemotherapy, 53(7), 2918-2927. [More Information]
  • Pulsipher, M., Boucher, K., Wall, D., Frangoul, H., Duval, M., Goyal, R., Shaw, P., Haight, A., Grimley, M., Grupp, S., et al (2009). Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood, 114(7), 1429-1436. [More Information]
  • Gea-Banacloche, J., Masur, H., da Cuhna, C., Chiller, T., Kirchoff, L., Shaw, P., Tomblyn, M., Cordonnier, C. (2009). Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplantation, 44(8), 489-494. [More Information]
  • Bhadri, V., Lee-Horn, L., Shaw, P. (2009). Safety and tolerability of cidofovir in high-risk pediatric patients. Transplant infectious disease : an official journal of the Transplantation Society, 11(4), 373-9. [More Information]

2008

  • Ozkaynak, M., Sahdev, I., Gross, T., Levine, J., Cheerva, A., Richards, M., Rozans, M., Shaw, P., Kadota, R. (2008). A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors - A pediatric blood and marrow transplant consortium study. Journal of Pediatric Hematology / Oncology, 30(3), 204-209. [More Information]
  • Alexander, S., Smith, N., Hu, M., Verran, D., Shun, A., Dorney, S., Smith, A., Webster, B., Shaw, P., Lammi, A., Stormon, M. (2008). Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant. New England Journal of Medicine, 358(4), 369-374. [More Information]
  • Strong, K., Kerridge, I., Jordens, C., Ankeny, R., Shaw, P., O'Brien, T., Carter, S., Barlow-Stewart, K. (2008). Creating 'Saviour Siblings' for transplantation-discrepancy between parental wishes and clinical practice. 50th American Society of Hematology Annual Meeting and Exposition ASH 2008, United States: American Society of Hematology.
  • Khan, N., Cisterne, A., Devidas, M., Shuster, J., Hunger, S., Shaw, P., Bradstock, K., Bendall, L. (2008). Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics. Leukemia and lymphoma, 49(4), 710-718. [More Information]
  • Zeng, L., Nath, C., Shaw, P., Earl, J., McLachlan, A. (2008). HPLC-fluorescence assay for acyclovir in children. Biomedical Chromatography, 22(8), 879-887. [More Information]
  • Nath, C., Earl, J., Pati, N., Stephen, K., Shaw, P. (2008). Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients. British Journal of Clinical Pharmacology, 66(1), 50-59. [More Information]

2007

  • Nath, C., McLachlan, A., Shaw, P., Coakley, J., Earl, J. (2007). Amphotericin B Dose Optimization in Children with Malignant Diseases. Chemotherapy, 53(2), 142-147. [More Information]
  • Nath, C., Shaw, P. (2007). Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Current Clinical Pharmacology, 2(1), 75-91. [More Information]
  • Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K., Gottlieb, D. (2007). Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13(6), 707-714. [More Information]
  • Howman-Giles, R., Shaw, P., Uren, R., Chung, D. (2007). Neuroblastoma and Other Neuroendocrine Tumors. Seminars in Nuclear Medicine, 37(4), 286-302. [More Information]
  • Nath, C., Shaw, P., Trotman, J., Zhang, Y. (2007). Pharmacokinetics of melphalan in myeloma patients undergoing an autograft. Bone Marrow Transplantation, 40(7), 707-8. [More Information]
  • Hong, Y., Shaw, P., Tattam, B., Nath, C., Earl, J., Stephen, K., McLachlan, A. (2007). Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases. European Journal of Clinical Pharmacology, 63(2), 165-172. [More Information]
  • Nath, C., Shaw, P., Montgomery, K., Earl, J. (2007). Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. British Journal of Clinical Pharmacology, 64(2), 151-164. [More Information]

2006

  • Park, J., Stewart, C., London, W., Santana, V., Shaw, P., Cohn, S., Matthay, K. (2006). A topotecan-containing induction regimen for treatment of high risk neuroblastoma. 2006 American Society of Clinical Oncology (ASCO) Annual Meeting, United States: American Society of Clinical Oncology.
  • Kakakios, A., Tugwell, H., Shaw, P. (2006). Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatric Blood and Cancer, 47, 327-9. [More Information]
  • Antonenas, V., Bradstock, K., Shaw, P., Gottlieb, D. (2006). Comparison between TNC and CD34+cell counts reported pre-cryopreservation of unrelated cord blood (UCB) units and those observed at the time of their transplantation. 2nd International Conference 'Strategies in Tissue Engineering', United Kingdom: Informa Healthcare.
  • Cuss, A., Avery, D., Cannons, J., Yu, L., Nichols, K., Shaw, P., Tangye, S. (2006). Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. Journal of Immunology, 176(3), 1506-1516. [More Information]
  • Petterson, T., Tiedemann, K., Teague, L., Shaw, P., Baker, D., Bolton-Jones, R., Oswald, C., O'Brien, T. (2006). Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: A report from the Australian and New Zealand children's haematology and oncology group (anzchog). 32nd Annual Meeting of the American Society for Blood and Marrow Transplantation, United States: Elsevier Ltd.
  • Bateman, C., Kesson, A., Shaw, P. (2006). Pancreatitis and adenoviral infection in children after blood and marrow transplantation. Bone Marrow Transplantation, 38(12), 807-811. [More Information]
  • Gandhi, M., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P., Prince, H., Wolf, M., Clarke, K., Underhill, C., et al (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12(2), 460-464.
  • Hong, Y., Shaw, P., Nath, C., Yadav, S., Stephen, K., Earl, J., McLachlan, A. (2006). Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases. Antimicrobial Agents and Chemotherapy, 50(3), 935-942. [More Information]
  • Halliday, C., Hoile, R., Sorrell, T., James, G., Yadav, S., Shaw, P., Bleakley, M., Bradstock, K., Chen, S. (2006). Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. British Journal of Haematology, 132(4), 478-486. [More Information]
  • Stephen, K., Montgomery, K., Bateman, C., Calandra, G., Shaw, P. (2006). Successful mobilisation, harvest, and transplant of stem cells following AMD3100 in 3 paediatric patients. The Australian experience. 32nd Annual Meeting of the American Society for Blood and Marrow Transplantation, United States: Elsevier Ltd.

2005

  • Spavor, M., Ahern, V., Shaw, P., Steinbeck, K., Somerville, E., Somerville, H. (2005). Beyond brain tumours and cognition: Neurological complications in long-term survivors of childhood non-central nervous system malignancies. 26th International Epilepsy Congress (IEC), United States: Blackwell Publishers.
  • Nath, C., Shaw, P., Montgomery, K., Earl, J. (2005). Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation. British Journal of Clinical Pharmacology, 59(3), 314-324. [More Information]

2004

  • Shaw, P., Nath, C., Berry, A., Earl, J. (2004). Busulphan Given As Four Single Daily Doses Of 150 Mg/M2 Is Safe And Effective In Children Of All Ages. Bone Marrow Transplantation, 34(3), 197-205.
  • Antonenas, V., Kerridge, I., Thomson, A., Trickett, A., Shaw, P., Bradstock, K. (2004). Development of a policy for the storage and disposal of cryopreserved haematopoietic progenitor cells for the NSW BMT Network Laboratories. Australian and New Zealand Transplant Society.
  • Gluckman, E., Shaw, P., Arcese, W., Michel, G., Sanz, G., Chan, K., Takahashi, T., Ortega, J., Filipovich, A., Locatelli, F., et al (2004). Factors Associated With Outcomes Of Unrelated Cord Blood Transplant: Guidelines For Donor Choice. Experimental Hematology, 32(4), 397-407. [More Information]
  • Antonenas, V., Shaw, P., Bradstock, K. (2004). Letter: Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation. Bone Marrow Transplantation, 34(8), 739.
  • Barbaric, D., Curtin, J., Pearson, L., Shaw, P. (2004). Role Of Hydrochloric Acid In The Treatment Of Central Venous Catheter Infections In Children With Cancer. Cancer, 101(8), 1866-1872. [More Information]

2003

  • Locatelli, F., Labopin, M., Ortega, J., Meloni, G., Dini, G., Messina, C., Yaniv, I., Fagioli, F., Castel, V., Shaw, P., et al (2003). Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood, 101(4), 1611-1619.
  • Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K., Filipovich, A., Takahashi, T., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P., et al (2003). Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group Analysis. Blood, 102(13), 4290-4297.

2002

  • Milledge, J., Shaw, P., Mansour, A., Williamson, S., Bennetts, B., Roscioli, T., Curtin, J., Christodoulou, J. (2002). Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood, 100(3), 774-777.
  • Smith, A., Shaw, P., Webster, B., Lammi, A., Gaskin, K., Diaz, S., Sharma, P. (2002). Intermittent 20q- and consistent i(7q) in a patient with Shwachman-Diamond syndrome. Pediatric Hematology and Oncology, 19(7), 525-528.

To update your profile click here. For support on your academic profile contact .